ADVFN - Advanced Financial Network.
HOME» NYSE » V » VRX Stock Price » VRX Stock News

Valeant Pharma Share News

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades

Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals

PARIS -(Dow Jones)- French drug company Sanofi-Aventis (SAN.FR) announced Monday the finalization of the sale of its Canadian dermatology business, Dermik, to Valeant Pharmaceuticals International Inc. (VRX) for $422.5 million. In a statement, Sanofi said the transaction includes an aesthetic and therapeutic business in the U.S. and Canada, as well as an aesthetic business around the world. Sanofi's Canadian unit will continue its operations in Greater Montreal, said the company. -By Nadya Masidlover, Dow Jones Newswires; +33 1 4017 1740; nadya.masidlover@dowjones.com

Stock News for Valeant Pharma (VRX)
DateTimeHeadline
11/29/201616:01:00Valeant Announces The Initiation Of A Primary Care Sales Force...
11/29/201616:01:00Valeant Announces The Initiation Of A Primary Care Sales Force...
11/22/201601:00:00Pharming Launches Rights Issue to Raise €12.1 Million as Part o...
11/21/201601:00:00Pharming Announces Financing Plans for Closing of RUCONEST®...
11/18/201607:40:00Chipotle, Ackman Near Settlement
11/18/201603:02:00Former Executives Accused In Fraud Against Valeant -- WSJ
11/17/201615:49:00U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging...
11/17/201614:46:00U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging...
11/17/201614:45:00Press Release: Former Valeant Executive and Former Philidor CEO...
11/17/201614:15:00U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging...
11/17/201613:16:00U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging...
11/17/201612:18:00U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging...
11/17/201611:42:00U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging...
11/17/201610:46:00Valeant Comments On Issued Philidor Criminal Charges
11/17/201610:46:00Valeant Comments On Issued Philidor Criminal Charges
11/17/201610:30:00Federal Prosecutors to Charge Two Valeant, Philidor Executives
11/17/201610:30:00U.S. Attorney to Charge Two Valeant, Philidor Executives, Alleging...
11/14/201616:30:00Medicare Identifies Which Prescription Drugs Were Costliest in...
11/14/201608:00:00Pharming Announces the Presentation of the Results of the RUCONEST®...
11/14/201601:00:00Pharming Announces Progress on Financing

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US